Muscle performance, sex hormones and training in peri-menopausal and post-menopausal women

Scandinavian Journal of Medicine and Science in Sports

Volumn 13, Issue 1, 2003, Pages 19-25

  Sipila S ^a   Poutamo, J ^b  

^a UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^b Central Hospital of Middle Finland   (Finland)

Author keywords

Estrogen; Estrone; Exercise; Muscle strength; Older women; Skeletal muscle

Indexed keywords

ESTRADIOL; ESTROGEN; ESTRONE; NANDROLONE; SEX HORMONE; TESTOSTERONE;

BODY COMPOSITION; CLIMACTERIUM; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; EXERCISE; EXPERIMENT; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HORMONE ACTION; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; MUSCLE FORCE; MUSCLE FUNCTION; MUSCLE STRENGTH; OVARY; PHYSICAL ACTIVITY; POSTMENOPAUSE; SKELETAL MUSCLE; TRAINING; ESTROGEN THERAPY; PHYSICAL EDUCATION; PHYSIOLOGY; REVIEW;

CLIMACTERIC; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MUSCLE, SKELETAL; PHYSICAL EDUCATION AND TRAINING; POSTMENOPAUSE;

EID: 0037799710     PISSN: 09057188     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0838.2003.20210.x     Document Type: Conference Paper

References (43)

1. Albertazzi P, Purdie DW. The life and time of the estrogen receptors: an interim report. Climacteric 2001: 4: 194-202.
2. Brown M, Birge SJ, Kohrt WM. Hormone replacement therapy does not augment gains in muscle strength or fat-free mass in response to weight-bearing exercise. J Gerontol 1997: 52A: B166-B170.
3. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989: 129: 1120-1131.
4. Cauley JA, Petrini AM, LaPorte RE, et al. The decline of grip strength in the menopause: relationship of physical activity, estrogen use and anthropometric factors. J Chron Dis 1987: 40: 115-120.
5. Cauley JA, Zmuda JM, Ensrud KE, Bauer DC, Ettinger B. Timing of estrogen replacement therapy for optimal osteoporosis prevention. J Clin Endocrin Metab 2001: 86: 5700-5705.
6. Dahlberg E. Characterization of the cytosolic estrogen receptor in rat skeletal muscle. Biochem Biophys Acta 1982: 717: 65-75.
7. Dionne FT, Dube JY, Frenette G, Tremblay RR. Effects of endocrine manibulations on oestrogen binding in cytosols from rat skeletal and perineal muscle. J Endocrinol 1980: 85: 351-358.
8. Dragovic T, Minhall R, Jackman HL, Wang L-X, Erdos EG. Kininase II-type enzymes: their putative role in muscle energy metabolism. Diabetes 1996: 45: S34-S37.
9. Dube JY, Lesage R, Tremblay RR. Androgen and estrogen binding in rat skeletal and perineal muscle. Can J Biochem 1976: 54: 50-55.
10. Greeves JP, Cable NT, Reilly T, Kingsland C. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci 1999: 97: 79-84.
11. Gustafsson JA, Saartok T, Dahlberg E, Snochwski M, Haggmark T, Eriksson E. Studies on steroid receptors in human and rabbit skeletal muscle - clues to the underestanding of the mechanism of action of anabolic steroids. Prog Clin Biol Res 1984: 142: 261-290.
12. Häkkinen K, Pakarinen A, Kraemer WJ, Häkkinen A, Valkeinen H, Alen M. Selective muscle hypertrophy, changes in EMG and force, and serum hormones during strength training in older women. J Appl Physiol 2001: 91: 569-580.
13. Häkkinen K, Pakarinen A, Kraemer WJ, Newton RU, Alen M. Basal concentrations and acute responses of serum hormones and strength development during heavy resistance training in middle-aged and elderly men and women. J Gerontol a Biol Sci Med Sci 2000: 55: B95-B105.
14. Häkkinen K, Pakarinen A. Serum hormone and strength development during strength training in middle-aged and elderly males and females. Acta Physiol Scand 1994: 150: 211-219.
15. Heikkinen J, Kyllönen E, Kurttila-Matero E, et al. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women. Maturitas 1997: 26: 139-149.
16. Joe I, Ramirez VD. Binding of estrogen and progesterone-BSA conjugates to glyseraldehyde-3-phosphate dehydrogenase (GAPDH) and the effects of the free steroids on GAPDH enzyme activity: physiological implications. Steroids 2001: 66: 529-538.
17. Kahlert S, Grohé C, Karas RH, Löbbert K, Neyses L, Vetter H. Effects of estrogen on skeletal myoblast growth. Biochem Bioph Res Co 1997: 232: 373-378.
18. Lamberts SWJ, van den Beld AW, van den Lely A-J. The endocrinology of aging. Science 1997: 278: 419-424.
19. Malayer JR, Gorski J. An integrated model of estrogen receptor action. Domest Anim Endocrin 1993: 10: 159-177.
20. McEwen B, Alves SE. Estrogen action in the central nervous system. Endocr Rev 1999: 20: 279-307.
21. McEwen B. The molecular and neuroanatomical basis for estrogen effects in the central nervous system. J Clin Endocr Metab 1999: 84: 1790-1797.
22. Meyer HH, Rapp M. Estrogen receptor in bovine skeletal muscle. J Anim Sci 1985: 60: 294-300.
23. Montgomery H, Clarkson P, Barnard M, et al. Angiotensin-converting- enzyme gene insertion/depletion polymprphism and response to physical training. Lancet 1999: 353: 541-545.
24. Mosca L, Collines P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 2001: 104: 499-503.
25. Nelson ME, Meredith CN, Dawson-Hughes B, Evans WJ. Hormone and bone mineral status in endurance-trained and sedentary postmenopausal women. J Clin Endocr Metab 1988: 66: 927.
26. Pfaffl MW, Lange IG, Daxenberger A, Meyer HHD. Tissue-specific expression pattern of estrogen receptors (ES): quantification of ERα and ERα mRNA with real-time RT-PCR. APMIS 2001: 109: 345-355.
27. Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci 1993: 84: 95-98.
28. Puah JA, Bailey CJ. Effects of ovarian hormones on glucose metabolism in mouse soleus muscle. Endocrinology 1985: 117: 1336-1340.
29. Rance NE, Max SR. Modulation of the cytosolic androgen receptor in striated muscle by sex steroids. Endocrinology 1984: 115: 862-866.
30. Rannevik G, Carlström K, Jeppsson S, Bjerre B, Svanberg L. A prospective long-term study in women from pre-menopause to post-menopause: changing profiles of gonadotrophins, oestrogens and androgens. Maturitas 1986: 8: 197-307.
31. Saartok T, Dahlberg E, Bylund P, Eriksson E, Gustafsson J-Å. Steroid hormone receptors, protein, and DNA in erector spinae muscle from scoliotic patients. Clin Orthop Relat R 1984: 197-207.
32. Saartok T. Steroid receptor in two types of rabbit skeletal muscle. Int J Sports Med 1984: 5: 130-136.
33. Seeley DG, Cauley JA, Grady D, Browner WS, Nevitt MC, Cummings SR. Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women? Arch Intern Med 1995: 155: 293-299.
34. Sipilä S, Multanen J, Kallinen M, Suominen H. Effects of strength and endurance training on isometric muscle strength and walking speed in elderly women. Acta Physiol Scand 1996: 156: 457-464.
35. Sipilä S, Suominen H. Effects of strength and endurance training on thigh and led muscle mass and composition in elderly women. J Appl Physiol 1995: 78: 334-340.
36. Sipilä S, Taaffe D, Cheng S, Puolakka J, Toivanen J, Suominen H. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci 2001: 101: 147-157.
37. Skelton DA, Phillips SK, Bruce SA, Naylor CH, Woledge RC. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. Clin Sci 1999: 96: 357-364.
38. Snieder H, MacGregor AJ, Spector TD. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocr Metab 1998: 83: 1875-1880.
39. Taaffe DR, Villa ML, Delay R, Marcus R. Maximal muscle strength of elderly women is not influenced by oestrogen status. Age Aging 1995: 24: 329-333.
40. Welshon WV, Lieberman ME, Gorski J. Nuclear localization of unoccupied oestrogen receptors. Nature 1984: 307: 747-749.
41. Wise PM, Krajnak KM, Kashon ML. Menopause: The aging of multiple pacemakers. Science 1996: 273: 67-70.
42. Wood AJJ. Hormonal treatment of postmenopausal women. New Engl J Med 1994: 330: 1062-1071.
43. Woods D, Onambele G, Woledge R, et al. Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density. J Clin Endocr Metab 2001: 86: 2200-2204.